Ximbio Expands Team
Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate.
Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue created from commercialisation of life science research reagents available through the Ximbio website. He has over six years’ experience in reagents sourcing and licensing, and has a broad network of key opinion leaders in academic and government laboratories throughout Europe.
Hugh joins Ximbio from Merck Millipore, where he was Business Development Manager with responsibility for identification and in-licensing of new research tools. Prior to this he was Senior Development Scientist at Orchid Biosciences, before joining Abcam as a Senior Technical Support Specialist and then moving to Millipore as a Field Applications Specialist.
Emily studied Biochemistry at Imperial College, and subsequently secured a placement with Imperial Innovations working with the technology transfer team. At Ximbio she is part of the Scientific Portfolio team, which sources exciting new reagents. Emily deals with Material Transfer Agreement queries and antibody sales, in addition to the assessment and diligence around new product deposits and the general management of Ximbio’s portfolio of research reagents.
Other news from the department people
